The End Game: Targeting Telomere Processing in Cancer
Imagine your DNA as a shoelace. What would happen to the ends if there were no aglets there to...
Author:
Neha J. Pancholi, PhD
Home »
Imagine your DNA as a shoelace. What would happen to the ends if there were no aglets there to...
Black Americans are more than twice as likely to die from prostate cancer than white Americans, highlighting a major...
Sometimes referred to as stage 0 breast cancer, ductal carcinoma in situ (DCIS) is a noninvasive growth of abnormal...
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are...
Twenty-three pairs of chromosomes make up the human genome of normal cells. But in 1965, researchers observed that in...
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
On December 23, 1971, when President Richard Nixon signed the National Cancer Act of 1971 into law, cancer was considered a death sentence. Only 42 percent of those diagnosed with cancer survived five years past diagnosis,...
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a...